FDA approves Eisai's seizure drug Fycompa for monotherapy use

FDA approved an sNDA from Eisai Co. Ltd. (Tokyo:4523) for Fycompa perampanel (E2007) as monotherapy to treat partial-onset seizures with or without secondarily generalized seizures in epileptics ages...